Private equity fund enters Lameplast Group which is an important choice to increase and extend the company's project all around the world.
To face the challenges of the future and make a qualitative leap on a global scale, Lameplast Group grows stronger with the entry of private equity fund Aksìa Group SGR, which has acquired 100% of the Group. The acquisition covers the three companies, Lameplast, COC Farmaceutici and the subsidiary LF of America, the overseas division based in Miami.
An important step to give a further boost to the Group, which now has even greater growth prospects capable of embracing the entire globe, but it is also a choice in line with the entrepreneurial values the Modena-based company has always advocated. The founding partners, Giovanni Ferrari, Evro Fabbri and Antonio Fontana, maintain their positions on the company's board of directors. Lameplast Group's courage, tenacity and ability to anticipate future necessities continue to guide it towards ever-greater projects that will spread its know-how and Made in Italy excellence around the world.